PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 116 filers reported holding PROVENTION BIO INC in Q4 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $84,687 | +123.2% | 3,514 | -2.1% | 0.00% | +100.0% |
| Q4 2022 | $37,936 | +134.9% | 3,589 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $16,151 | +253.6% | 3,589 | +214.3% | 0.00% | – |
| Q2 2022 | $4,568 | -83.9% | 1,142 | -70.5% | 0.00% | -100.0% |
| Q1 2022 | $28,328 | -4.6% | 3,870 | -26.7% | 0.00% | – |
| Q4 2021 | $29,679 | -28.9% | 5,281 | -19.1% | 0.00% | -100.0% |
| Q3 2021 | $41,754 | -64.1% | 6,524 | -52.7% | 0.00% | -50.0% |
| Q2 2021 | $116,174 | -9.7% | 13,781 | +12.4% | 0.00% | 0.0% |
| Q1 2021 | $128,627 | -44.0% | 12,256 | -9.6% | 0.00% | -33.3% |
| Q4 2020 | $229,588 | +32.0% | 13,553 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $173,885 | -9.1% | 13,553 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $191,233 | – | 13,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 14,879,023 | $157,271,273 | 9.67% |
| MPM BioImpact LLC | 898,483 | $9,496,965 | 2.46% |
| VR Adviser, LLC | 1,118,653 | $11,824,162 | 1.99% |
| Ghost Tree Capital, LLC | 400,000 | $4,228,000 | 1.80% |
| EAM Investors, LLC | 276,250 | $2,919,963 | 0.60% |
| EAM Global Investors LLC | 209,856 | $2,218,178 | 0.57% |
| 683 Capital Management, LLC | 550,000 | $5,813,500 | 0.49% |
| Palo Alto Investors LP | 390,800 | $4,130,756 | 0.35% |
| CABOT WEALTH MANAGEMENT INC | 184,271 | $1,948 | 0.33% |
| ADVISORY RESEARCH INC | 288,707 | $3,051,633 | 0.29% |